CPT1A: The Potential Drug Target and Biomarker (G1374)

Target Name: CPT1A

NCBI ID: G1374

CPT1A

CPT1A: The Potential Drug Target and Biomarker

CPT1A, also known as CPT-1A, is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is a key regulator of the cellular processes that are responsible for the production and release of insulin, which is a hormone that plays a crucial role in regulating blood sugar levels.

The discovery of CPT1A as a potential drug target and biomarker has significant implications for the treatment of various diseases, including diabetes. Insulin is widely used to manage the symptoms of diabetes, but it is often associated with several side effects, including an increased risk of hypoglycemia (low blood sugar) and an increase in the risk of cardiovascular diseases.

CPT1A has been shown to play a crucial role in the regulation of insulin secretion and sensitivity. Studies have shown that CPT1A plays a key role in the development of insulin resistance, which is a condition in which the body's cells become less responsive to insulin, making it difficult for glucose to enter the cells. This is a key precursor to the development of type 2 diabetes.

In addition, CPT1A has also been shown to play a role in the regulation of muscle glucose uptake and storage. This is important for maintaining muscle mass and function, as muscle is the body's primary source of glucose.

CPT1A has also been shown to be involved in the regulation of inflammation. Studies have shown that CPT1A plays a key role in the regulation of immune cells, including T cells, which are responsible for fighting off infections and diseases. This is important for maintaining the body's immune system and protecting against diseases.

The potential drug target for CPT1A is related to the regulation of insulin secretion and sensitivity, as well as the regulation of muscle glucose uptake and storage. This makes it an attractive target for drug development, as it has the potential to improve insulin sensitivity and muscle function, as well as reducing the risk of cardiovascular diseases and improving the immune system's response to infections and diseases.

In conclusion, CPT1A is a protein that has significant implications for the treatment of various diseases, including diabetes. Its role in the regulation of insulin secretion and sensitivity, as well as its involvement in the regulation of muscle glucose uptake and storage, makes it an attractive target for drug development. Further research is needed to fully understand the potential mechanisms of CPT1A as a drug target and biomarker, and to develop safe and effective treatments for the management of diabetes and other diseases.

Protein Name: Carnitine Palmitoyltransferase 1A

Functions: Catalyzes the transfer of the acyl group of long-chain fatty acid-CoA conjugates onto carnitine, an essential step for the mitochondrial uptake of long-chain fatty acids and their subsequent beta-oxidation in the mitochondrion (PubMed:9691089, PubMed:11350182, PubMed:14517221). Plays an important role in hepatic triglyceride metabolism (By similarity)

The "CPT1A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CPT1A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets